Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abpro, Algia, Amphastar, Anavex, Biocryst, Celltrion, Fibrogen, Fortress, Innoviva, Janssen, Lenz, Leo, LIB, Milestone, Moderna, Pilatus, Sanofi, Vanda.